At the Rosell® Institute for Microbiome and Probiotics, our mission is to apply leading-edge technologies and innovative scientific approaches to the improvement of human health through understanding the interaction between people and their functional microbiome.
Through intensive investigation and collaborative studies, our research is focused on understanding the potential of the human microbiome and to remap its functionality using probiotic supplements as a means to improve or maintain health in specific populations or health segments.
Our research is focused on harnessing the human microbiome to achieve the capability of remapping the microbiota composition using probiotic supplements as a means to improve or maintain health in specific populations or health segments.
With over 85 years of know-how, we have 40+ proprietary bacteria strains and over 500+ formulations in our growing portfolio for all major health segments. Worldwide our products are used in over 60 countries and reach millions of patients. Our research team has published more than 330 in vitro, in vivo and clinical research studies working with industry leaders, key opinion leaders, and scientific experts.
In 2019, we founded our Innovation Program which focuses on research to improve the understanding of dietary intervention with probiotics. To learn more about this program, click here.
The Rosell® Institute is one of the research centers of Lallemand Health Solutions. A global multinational company recognized as a vertically integrated lab to shelf leader in the manufacturing of probiotics that improve human health.